Dear NSGO investigators and study nurses
It is my pleasure to invite you to the autumn NSGO-CTU Investigator Meeting on 25 November, 2014, at ParkInn, Engvej 171, 2300 Copenhagen.
This year we have the honour of having two prominent external speakers:
Jonathan Ledermann, NCRI, UK, who will give a talk about PARP inhibitors and Antonio González Martin, GEICO, Spain, who will discuss the role of anti-angiogenic therapy in the gynaecologic malignancies.
We have invited Elisabeth Lassen to give a presentation of RECIST 1.1. This session was suggested by NSGO Study Nurse Sub-committee and is highly relevant for both investigators and study nurses.
Stella Nielsen will introduce to the Nordic Monitoring Network (NORM) and we will as well have a kick-off investigator meeting on the long awaited INOVATYON study.
I am looking forward to your participation. Kindly note that there is no limit of attendees per site, though NSGO will be able to reimburse economy class travel for one investigator and one study nurse from each site.
This meeting is partly sponsored by AstraZeneca and Roche.
Mansoor Raza Mirza